As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

William L. Atkinson, MD, MPH

Medical Epidemiologist, National Center for Immunology and Respiratory Disease, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: William L. Atkinson, MD, MPH, has disclosed no relevant financial relationships.

Dr. Atkinson does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Atkinson does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Karen R. Broder, MD

Team Lead, Surveillance and Public Health Response Team, Immunization Safety Office, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: Karen R. Broder, MD, has disclosed no relevant financial relationships.

Dr. Broder does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Broder does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Timothy M. Uyeki, MD, MPH, MPP

Medical Epidemiologist, Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: Timothy M. Uyeki, MD, MPH, MPP, has disclosed no relevant financial relationships.

Dr. Uyeki does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Uyeki does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Susan L. Smith, MN, PhD

Scientific Director, Medscape LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Laurie E. Scudder, DNP, NP

Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

Disclosures

Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.

CME/CE

Real Talk About Influenza Vaccine Safety -- Be Informed and Be Prepared

Authors: William L. Atkinson, MD, MPH; Karen R. Broder, MD; Timothy M. Uyeki, MD, MPH, MPP
CME/CE Released: 11/30/2010; Reviewed and Renewed: 11/23/2011
THIS ACTIVITY HAS EXPIRED
Valid for credit through: 11/30/2012

Start Activity

Target Audience and Goal Statement

This activity is intended for clinicians who routinely administer influenza vaccines and who evaluate and treat patients experiencing adverse events after influenza immunization, including family medicine and internal medicine physicians, pediatricians, obstetricians/gynecologists, nurse practitioners, physician assistants, and nurses.

The intended goals of this program are to educate clinicians on the following topics:

The safety profiles of licensed influenza vaccines
The safe administration of influenza vaccines and screening for contraindications and precautions
The resources available for communicating benefits and risks of influenza vaccination
The accurate and timely reporting of any adverse events to the Vaccine Adverse Event Reporting System (VAERS)

Upon completion of this activity, participants will be able to:

Apply the updated Advisory Committee on Immunization Practices recommendations for influenza immunization
Separate fact from fiction about vaccine safety
Demonstrate appropriate use of the VAERS

Disclosures

Author(s)

William L. Atkinson, MD, MPH

Medical Epidemiologist, National Center for Immunology and Respiratory Disease, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: William L. Atkinson, MD, MPH, has disclosed no relevant financial relationships.

Dr. Atkinson does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Atkinson does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Karen R. Broder, MD

Team Lead, Surveillance and Public Health Response Team, Immunization Safety Office, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: Karen R. Broder, MD, has disclosed no relevant financial relationships.

Dr. Broder does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Broder does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Timothy M. Uyeki, MD, MPH, MPP

Medical Epidemiologist, Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia

Disclosures

Disclosure: Timothy M. Uyeki, MD, MPH, MPP, has disclosed no relevant financial relationships.

Dr. Uyeki does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Uyeki does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Susan L. Smith, MN, PhD

Scientific Director, Medscape LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Laurie E. Scudder, DNP, NP

Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing and Allied Health, George Washington University, Washington, DC

Disclosures

Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For Nurses

Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Safe Use

CME/CE

Real Talk About Influenza Vaccine Safety -- Be Informed and Be Prepared

Authors: William L. Atkinson, MD, MPH; Karen R. Broder, MD; Timothy M. Uyeki, MD, MPH, MPPFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED

CME/CE Released: 11/30/2010; Reviewed and Renewed: 11/23/2011

Valid for credit through: 11/30/2012

processing....

Download Audio

Download Slides

View Transcript

This feature requires the newest version of Flash. You can download it here.

CME/CE Information

Print
Like Tweet

Disclaimer

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on www.medscapecme.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Author(s)

William L. Atkinson, MD, MPH

Karen R. Broder, MD

Timothy M. Uyeki, MD, MPH, MPP

Editor(s)

Susan L. Smith, MN, PhD

CME Reviewer/Nurse Planner

Laurie E. Scudder, DNP, NP

CME/CE

Real Talk About Influenza Vaccine Safety -- Be Informed and Be Prepared

Target Audience and Goal Statement

Disclosures

Author(s)

William L. Atkinson, MD, MPH

Karen R. Broder, MD

Timothy M. Uyeki, MD, MPH, MPP

Editor(s)

Susan L. Smith, MN, PhD

CME Reviewer/Nurse Planner

Laurie E. Scudder, DNP, NP

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Real Talk About Influenza Vaccine Safety -- Be Informed and Be Prepared